Stay updated on Efficacy of EID Natalizumab in RRMS Clinical Trial
Sign up to get notified when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.

Latest updates to the Efficacy of EID Natalizumab in RRMS Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating restricted access to the page.SummaryDifference19%

- Check30 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a page update rather than substantive changes to the study details.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a newer build of the page/template. This is a software/documentation update rather than a change to the study content or results.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded an NIH funding reference '2018 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers, indicating U.S. NIH support for the study. This clarifies the study's funding source and provenance.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling a minor version update to the page assets or documentation.SummaryDifference0.0%

Stay in the know with updates to Efficacy of EID Natalizumab in RRMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.